D-Dimer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The D-Dimer Market is segmented by Testing Method (Point of Care Testing and Laboratory Testing), Application, Distribution Channel, and Geography

D-Dimer Market Snapshot

D-Dimer Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >5.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The D-Dimer Market is anticipated to witness a healthy CAGR over the forecast period. The major factors driving the growth of the market are the rising global prevalence of pathological conditions like multiple cardiovascular indications, acute coronary syndromes, arterial or venous thromboembolism, and atrial fibrillation and non-pathological conditions such as rise in the geriatric population where the levels of D-dimer increase in the blood plasma. For instance, according to the Global Health And Wellness Report published in 2018, about 40% of the adults in United States have been diagnosed with some or other cardiovascular condition related to blood disorders which directly resulted in higher demand for efficient treatments and advanced coagulation testing techniques fueling the growth of the market throughout the forecasted period.

Scope of the Report

D-dimer is a fibrin degradation product (FDP) which has two cross-linked D fragment of fibrin formed by the degradation of blood clot known as fibrinolysis. D-dimers form in the blood plasma only when the blood coagulation system gets activated due to disseminated intravascular coagulation or thrombosis and thus activates the hemostatic system. The demand for D-dimer tests is increasing due to their cost effectiveness, high accuracy and lack of radiological interventions which drive the global D-dimer market revenue.

By Testing Method
Point of Care Testing
Laboratory Testing
By Application
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Venous Thromboembolism (VTE)
Others
By Distribution Channel
Diagnostic Laboratories
Hospitals
Others
Geography
North America
United states
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Pulmonary Embolism Segment is Expected to Witness a Robust Growth Over the Forecast Period

  • Growth of the pulmonary embolism segment is attributed to the growing global prevalence of this disease due to rise in blood plasma d-dimer levels among women and the rising geriatric population coupled with a higher burden of associated diseases. On the other hand, Deep Venous Thrombosis (DVT) testing is also likely to witness the highest growth rate over the forecast period due to the rise in a number of new cases across the world. For instance, according to the National Health Service (NHS) fact sheet (2019), every year, DVT affects one in every 1,000 individuals in the United Kingdom coupled with obese population and people over the age of 40. This factor is fueling the segment and contributing to the growth of global market revenue.
  • Based on the end-users, the hospital segment is expected to dominate the d-dimer market. The dominance is due to a rise in the number of patients admitted to the hospitals for the early diagnosis of cardiovascular diseases and blood disorders as prescribed by physicians. On the other hand, the diagnostic laboratories are likely to witness the highest growth due to adoption of advanced technologies and availability of novel systems like Cobas h 232 POC system in the developed countries which can be used in different settings like ambulances, and emergency rooms driving the global d-dimer market over the forecast period.
D-Dimer Market

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall D-Dimer market throughout the forecast period. The dominance is due to the rising prevalence of cardiopulmonary disorders and blood disorders such as venous thromboembolism, strokes, disseminated intravascular coagulation among the huge population of elder individuals which generates higher demand for the D-Dimer test market. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC) in March 2019, the risk of Deep vein thrombosis (DVT) increases with rise in obesity and age over 50. It has been estimated by CDC that about 900,000 people in the United States could be affected every year with DVT which directly drives for growth of the D-dimer testing market in the region. Also, a rise in the approvals from regulatory authorities along with ongoing clinical trial studies and increasing adoption of technology by the key players in the United States are likely to contribute the largest share of revenue in the region propelling the global D-Dimer market.

D-Dimer Market

Competitive Landscape

The D-Dimer market is moderately competitive and consists of several major players. Few of the key players are entering into partnerships to develop novel methods and test kits while others are increasing their salesforce through partnering with the distributors to increase their market position globally. For instance, In October 2017, Abbott acquired Alere Inc, a global manufacturer of rapid point-of-care diagnostics and emerged as one of the leading point of care testing portfolio achieving leadership positions in key business segments across the geographies which is expected to impel the global D-Dimer market growth throughout the forecast period. Some of the companies which are currently dominating the market are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens AG, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Geriatric Population Along with Rise in Disposable Income

      2. 4.2.2 Rise in Global Prevalence of Cardiopulmonary Disorders such as Stroke and Pulmonary Embolism

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulation

      2. 4.3.2 Limitations Associated with the Tests

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Testing Method

      1. 5.1.1 Point of Care Testing

      2. 5.1.2 Laboratory Testing

    2. 5.2 By Application

      1. 5.2.1 Deep Vein Thrombosis (DVT)

      2. 5.2.2 Pulmonary Embolism (PE)

      3. 5.2.3 Venous Thromboembolism (VTE)

      4. 5.2.4 Others

    3. 5.3 By Distribution Channel

      1. 5.3.1 Diagnostic Laboratories

      2. 5.3.2 Hospitals

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United states

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Bio-Rad Laboratories Inc

      3. 6.1.3 Danaher Corporation

      4. 6.1.4 Beckton Dickinson

      5. 6.1.5 BioMerieux

      6. 6.1.6 F Hoffmann-La Roche AG

      7. 6.1.7 Siemens AG

      8. 6.1.8 Sysmex Corporation

      9. 6.1.9 Merck KGaA

      10. 6.1.10 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The D-Dimer Market market is studied from 2018 - 2026.

The D-Dimer Market is growing at a CAGR of >5.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific, Abbott Laboratories, Siemens AG are the major companies operating in D-Dimer Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!